We are international
Donate
TEXT SIZE   
back

ASH 2011: Dr. Ludwig - Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians
Heinz Ludwig, MD
Wilhelminenhospital
Vienna, Austria
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles